E. Gerald Kay

2023

In 2023, E. Gerald Kay earned a total compensation of $219K as Executive Chairman and President at Integrated Biopharma, a 24% decrease compared to previous year.

Compensation breakdown

Option Awards$25,464
Salary$163,589
Other$29,834
Total$218,987

Kay received $163.6K in salary, accounting for 75% of the total pay in 2023.

Kay also received $25.5K in option awards and $29.8K in other compensation.

Rankings

In 2023, E. Gerald Kay's compensation ranked 2,548th out of 2,770 executives tracked by ExecPay. In other words, Kay earned more than 8.0% of executives.

ClassificationRankingPercentile
All
2,548
out of 2,770
8th
Division
Manufacturing
1,410
out of 1,516
7th
Major group
Chemicals And Allied Products
807
out of 855
6th
Industry group
Drugs
782
out of 821
5th
Industry
Pharmaceutical Preparations
559
out of 590
5th
Source: SEC filing on October 28, 2024.

Kay's colleagues

We found three more compensation records of executives who worked with E. Gerald Kay at Integrated Biopharma in 2023.

2023

Dina Masi

Integrated Biopharma

Chief Financial Officer

2023

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2023

Christina Kay

Integrated Biopharma

Chief Executive Officer

News

You may also like